Johns Hopkins researchers develop new way to deliver sight-saving gene therapy to the retina: vision-research.eu

In experiments with rats, pigs and monkeys, Johns Hopkins Medicine researchers have developed a way to deliver sight-saving gene therapy to the retina.

If proved safe and effective in humans, the technique could provide a new, more permanent therapeutic option for patients with common diseases such as wet age-related macular degeneration (AMD), and it could potentially replace defective genes in patients with inherited retinal disease.

vision-research.eu - The Gateway to European Vision Research

Johns Hopkins researchers develop new way to deliver sight-saving gene therapy to the retina

Related Links